Drug Type CAR-T |
Synonyms |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Go Therapeutics, Inc.Startup |
Active Organization Go Therapeutics, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | Go Therapeutics, Inc.Startup | - |
Esophageal Carcinoma | Preclinical | US | Go Therapeutics, Inc.Startup | - |
Liver Cancer | Preclinical | US | Go Therapeutics, Inc.Startup | - |
Stomach Cancer | Preclinical | US | Go Therapeutics, Inc.Startup | - |